On 28 January 2015
Ranbaxy Laboratories will hold a meeting of the Board of Directors of the Company on 28 January 2015, to consider and approve Standalone and Consolidated Unaudited Financial Results for the third quarter and nine months ending December 31, 2014 (Q3) as reviewed by the Statutory Auditors of the Company.Powered by Capital Market - Live News
